The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: DiagnoCure

Monday Biotech Deal Review: February 22, 2010

There was a lot of follow-up among Canadian biotech deals this week: letters of intent turning into definitive agreements, merged companies turning to consolidation, bids launched on schedule and wrapped up; as well as an average crop of new M&Eh and securities.  Start things off with an interesting (cross-border!) twist to the SIFT/SR&ED deals we’ve [...]

Monday Deal Review: July 27, 2009

Well, July is wrapping up with no sign of summer, or of the summer doldrums.  Read on for all the rainy-day deals we found this week

Monday Deal Review: June 29, 2009

This week’s Monday Deal Review has a full set of equity deals from shelf to launch to close, one new U.S. registration and one deregistration to match, and some ideas for what to do with your debt (!), all

Monday Deal Review: May 4, 2009

Canadian deal and company news this week: Big drama at Patheon’s AGM, a public offering (!), some collaboration news and a completed private placement.

Friday Science Review: February 20, 2009

Cool Canadian science stories this week… A University of Ottawa Heart Institute (UOHI) research team showed that a DNA sequence variant facilitates rapid weight loss in people who are dieting by increasing the activity levels of ACSL5, among the first genes associated with weight loss. The study was published in FASEB J. The results of [...]

Follow

Get every new post delivered to your Inbox.

Join 92 other followers